Definitive Healthcare Corp., a United States-based company specializing in health software solutions, has recently been the subject of market attention due to its performance on the Nasdaq stock exchange. As of August 31, 2026, the company’s stock closed at $0.9023, reflecting a significant decline from its 52-week high of $4.35, recorded on September 22, 2025. This downturn is further highlighted by the stock reaching a 52-week low of $0.61 on August 16, 2026.
Operating within the Health Care sector, Definitive Healthcare Corp. is known for its healthcare commercial intelligence solutions, which encompass healthcare analytics and data management. These services are designed to support a global customer base, underscoring the company’s international reach and influence in the health technology domain.
The company’s market capitalization stands at $137.6 million, indicating its valuation in the current market landscape. However, the financial metrics reveal some challenges, with a Price Earnings (P/E) ratio of -0.5. This negative P/E ratio suggests that the company is currently not generating profits, which may be a contributing factor to the stock’s volatility and declining price.
Definitive Healthcare Corp. continues to operate under its official website, www.definitivehc.com , providing a platform for accessing its suite of healthcare solutions. Despite the recent stock performance, the company remains a key player in the health technology sector, offering critical data management and analytics services to healthcare providers and organizations worldwide.
As the company navigates the complexities of the market, stakeholders and investors will be closely monitoring its strategies to enhance profitability and stabilize its stock performance. The ongoing developments in the health technology landscape may also present opportunities for Definitive Healthcare Corp. to leverage its expertise and expand its market presence.
